Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
International Journal of Molecular Sciences · 21.07.2024 · 25 (14) · 7952
DOI: 10.3390/ijms25147952 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.07.2024. Verfasst von Eui-Hwan Choi und 2 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu 41061, Republic of Korea. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Mitochondria, Neurodegenerative Diseases, Mitochondrial Dynamics. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, The National Research Foundation of Korea (NRF) funded by the Korea government (MSIT), Korean government (MSIT).
Abstract (Originalsprache)
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common neurodegenerative diseases, and they affect millions of people worldwide, particularly older individuals. Therefore, there is a clear need to develop novel drug targets for the treatment of age-related neurodegenerative diseases. Emerging evidence suggests that mitochondrial dysfunction and reactive oxygen species (ROS) generation play central roles in the onset and progression of neurodegenerative diseases. Mitochondria are key regulators of respiratory function, cellular energy adenosine triphosphate production, and the maintenance of cellular redox homeostasis, which are essential for cell survival. Mitochondrial morphology and function are tightly regulated by maintaining a balance among mitochondrial fission, fusion, biogenesis, and mitophagy. In this review, we provide an overview of the main functions of mitochondria, with a focus on recent progress highlighting the critical role of ROS−induced oxidative stress, dysregulated mitochondrial dynamics, mitochondrial apoptosis, mitochondria-associated inflammation, and impaired mitochondrial function in the pathogenesis of age-related neurodegenerative diseases, such as AD and PD. We also discuss the potential of mitochondrial fusion and biogenesis enhancers, mitochondrial fission inhibitors, and mitochondria-targeted antioxidants as novel drugs for the treatment of these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu 41061, Republic of Korea.
ORCID-Profile: Eui-Hwan Choi, Sun-Ji Park
Förderung
- The Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning
- The National Research Foundation of Korea (NRF) funded by the Korea government (MSIT)
- Korean government (MSIT)
- Ministry of Science, ICT, and Future Planning
Zitieren
APA
Choi, E. H., Kim, M. H., & Park, S. J. (2024). Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment. International Journal of Molecular Sciences, 25(14), 7952. https://doi.org/10.3390/ijms25147952
Vancouver
Choi EH, Kim MH, Park SJ. Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment. International Journal of Molecular Sciences. 2024;25(14):7952. doi:10.3390/ijms25147952
BibTeX
@article{Choi2024,
author = {Choi, Eui-Hwan and Kim, Mi-Hye and Park, Sun-Ji},
title = {Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {14},
pages = {7952},
doi = {10.3390/ijms25147952}
}
EUVIMED